Artificial intelligence can be used as a framework to improve pharmaceutical processes from the lab to clinical trials by focusing on automated, assistive, analytical, accelerated and augmented intelligence, writes Andrew Satz, a data scientist and CEO and cofounder of EVQLV. Companies that follow this thinking can use AI in practical ways to improve a variety of outcomes, he adds.
A study published in Health Affairs has found that most Medicare Part D plans design formularies to prioritize generic drugs over brand-name counterparts, and in cases where branded drugs are preferred, costs remain low regardless of which drug is prescribed. Analysis of more than 4.1 million Part D plan and product combinations found that just the generic form of a drug was covered 84% of the time, branded and generic forms were covered 15% of the time and brand-name drugs were preferred in remaining instances.
The FDA has approved GlaxoSmithKline's BLENREP, or belantamab mafodotin, for treating adults with relapsed/refractory multiple myeloma who no longer had immunomodulatory agent treatment response. The drug's approval was also recommended by a European Medicines Agency panel last month.
Massaschusetts General Hospital created a "Pink Card" program where women were given a pink business card during their physician visits to remind them to get a mammogram. Researchers in the Journal of the American College of Radiology say 19.9% of the more than 3,600 women who were screened at OB/GYN centers that participated in the program used the "Pink Card" and were more likely to be Black or Asian and covered by Medicaid.
The ACR, Radiological Society of North America and American Association of Physicists in Medicine are collaborating on the development of the open-source Medical Imaging and Data Resource Center database, containing imaging scans from tens of thousands of COVID-19 patients, aimed at improving COVID-19 understanding, diagnosis, monitoring and treatment. ACR Chief Research Officer Dr. Etta Pisano and ACR Chief Information Officer and Executive Vice President Michael Tilkin will represent ACR in the MIDRC effort, which will eventually be used to combat other diseases as well. "The MIDRC database will provide a critical tool to help the medical imaging community, doctors and scientists better understand COVID-19 and its biological effects on humans," Pisano said.
A study in Academic Radiology showed that professional radiology organizations, especially interventional radiology groups, have increased their Twitter usage Twitter for self-promotion and information dissemination, particularly during the workweek. "Engagement of diagnostic and interventional radiology societies is essential to increase the awareness of the fields by engaging with the general public, patient advocacy groups, other specialties, and government health authorities," researchers wrote.
Adopting a concierge service may help radiology providers improve productivity by 5% to 10%, while increasing patient and referring provider satisfaction ratings, said Reed Humphrey of Canopy Partners at the Radiology Business Management Association's virtual annual meeting. Humphrey and co-presenter Laurie Shoaf said that designating professional radiology assistants and deploying instant messaging, scheduling software, communication tracking, streamlined phone systems and smart worklists are crucial for the success of concierge strategies.
Radiology practices will see an 11% reduction in reimbursement overall and potentially insufficient reimbursement for CT studies under rules proposed by the CMS, according to ACR, which said it would "use every avenue available to work with Congress to modify the impact of these changes." Congress must act to suspend the budget neutrality requirement, ACR said.
The daily number of COVID-19 tests administered across the US dropped 3.6% to 750,000 over the past two weeks -- possibly due to frustrations with long lines and delayed results -- even as deaths continue to increase and confirmed infections surpassed 4.7 million. Concerns about reduced testing prompted experts at Harvard's Global Health Institute to call for distribution of $1 saliva-based antigen tests to all Americans for regular testing, an approach they say would detect five times more COVID-19 infections than the existing system, even though the paper-based tests have lower accuracy.
Using hydroxychloroquine together with other therapies, but not hydroxychloroquine use alone, had a significant association with elevated 30-day all-cause mortality risk in individuals with cancer and confirmed COVID-19, according to a study published in Cancer Discovery. Remdesivir treatment correlated with reduced death risk but it wasn't statistically significant, according to the study.